J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 67 (1986), 591-595; DOI 10.1099/0022-1317-67-3-591
© 1986 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gould, E. A.
Right arrow Articles by Cammack, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gould, E. A.
Right arrow Articles by Cammack, N.
Agricola
Right arrow Articles by Gould, E. A.
Right arrow Articles by Cammack, N.

Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in Mice

E. A. Gould, A. Buckley, A. D. T. Barrett and N. Cammack

London School of Hygiene and Tropical Medicine, Arbovirus Research Unit, Winches Farm Field Station, 395 Hatfield Road, St Albans, Hertfordshire AL4 0XQ, U.K.

The capacity of monoclonal antibodies to protect mice passively against yellow fever (YF) virus infection was investigated. Both neutralizing (54K-specific) and non-neutralizing (54K- and 48K-specific) antibodies protected mice against challenge with the RMP substrain of YF virus. Average survival times of mice inoculated intracerebrally with a standard lethal dose of YF virus differed according to the strain used: thus mice inoculated with the most neurovirulent viruses, FNV and Asibi, survived for 6.50 and 7.65 days respectively, and those with RMP virus survived for 15.75 days. The capacity of antibodies to protect mice passively against virus challenge was directly related to virus neurovirulence. Possible mechanisms and the significance of protection by antibodies against non-structural proteins that do not mediate neutralization, are discussed.

Keywords: YF virus, monoclonal antibodies, passive protection

Received 30 September 1985; accepted 9 December 1985.


This article has been cited by other articles:


Home page
J. Virol.Home page
S. Sukupolvi-Petty, S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont, et al.
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
J. Virol., December 1, 2007; 81(23): 12816 - 12826.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Schlesinger
Flavivirus nonstructural protein NS1: Complementary surprises
PNAS, December 12, 2006; 103(50): 18879 - 18880.
[Full Text] [PDF]


Home page
J. Virol.Home page
K. M. Chung, G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont, and M. S. Diamond
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc {gamma} Receptor-Dependent and -Independent Mechanisms
J. Virol., February 1, 2006; 80(3): 1340 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Mehlhop, K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond
Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection
J. Virol., June 15, 2005; 79(12): 7466 - 7477.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Men, T. Yamashiro, A. P. Goncalvez, C. Wernly, D. J. Schofield, S. U. Emerson, R. H. Purcell, and C.-J. Lai
Identification of Chimpanzee Fab Fragments by Repertoire Cloning and Production of a Full-Length Humanized Immunoglobulin G1 Antibody That Is Highly Efficient for Neutralization of Dengue Type 4 Virus
J. Virol., May 1, 2004; 78(9): 4665 - 4674.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. S. Gritsun, T. V. Frolova, A. I. Zhankov, M. Armesto, S. L. Turner, M. P. Frolova, V. V. Pogodina, V. A. Lashkevich, and E. A. Gould
Characterization of a Siberian Virus Isolated from a Patient with Progressive Chronic Tick-Borne Encephalitis
J. Virol., December 6, 2002; 77(1): 25 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Verrier, A. Nadas, M. K. Gorny, and S. Zolla-Pazner
Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6
J. Virol., October 1, 2001; 75(19): 9177 - 9186.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Ourmanov, M. Bilska, V. M. Hirsch, and D. C. Montefiori
Recombinant Modified Vaccinia Virus Ankara Expressing the Surface gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques
J. Virol., March 15, 2000; 74(6): 2960 - 2965.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
M. Fleeton, B. Sheahan, E. Gould, G. Atkins, and P Liljestrom
Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
J. Gen. Virol., May 1, 1999; 80(5): 1189 - 1198.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1986 by the Society for General Microbiology.